Inozyme Pharma, Inc.

NasdaqGS:INZY Stock Report

Market Cap: US$300.0m

Inozyme Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:INZY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Aug 23BuyUS$7,999,997Longitude Capital Management Co., LLCCompany1,666,666US$4.80
01 Aug 23BuyUS$3,999,998Pivotal BioVenture Partners LLCCompany833,333US$4.80

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of INZY?
Owner TypeNumber of SharesOwnership Percentage
Private Companies4070.000658%
Individual Insiders320,9470.519%
General Public5,670,9259.17%
Hedge Funds9,010,03014.6%
VC/PE Firms14,616,20423.6%
Institutions32,236,99652.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 40.5%.


Top Shareholders

Top 25 shareholders own 84.75% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.44%
Longitude Capital Management Co., LLC
5,841,045US$28.3m0%6.03%
8.62%
Adage Capital Management, L.P.
5,328,856US$25.8m-3.77%0.05%
7.27%
Pivotal BioVenture Partners LLC
4,494,851US$21.8m0%9.7%
6.92%
Sofinnova Investment, Inc.
4,280,308US$20.8m0%1.25%
5.95%
Rock Springs Capital Management LP
3,681,174US$17.9m0%0.48%
5.14%
Eventide Asset Management, LLC
3,179,837US$15.4m0%0.26%
4.99%
BlackRock, Inc.
3,088,653US$15.0m1.52%no data
4.71%
Samlyn Capital, LLC
2,912,913US$14.1m-13.6%0.23%
4.27%
Affinity Asset Advisors, LLC
2,642,519US$12.8m40.1%2.36%
3.94%
New Enterprise Associates, Inc.
2,437,689US$11.8m0%0.73%
3.91%
The Vanguard Group, Inc.
2,419,020US$11.7m1.43%no data
3.18%
FMR LLC
1,967,357US$9.5m-13.4%no data
2.53%
Samsara BioCapital LLC
1,562,500US$7.6m0%1.56%
2.22%
Sphera Funds Management Ltd
1,372,907US$6.7m-12.2%1.08%
2.05%
CHI Advisors LLC
1,270,027US$6.2m0%1.99%
1.73%
Geode Capital Management, LLC
1,067,479US$5.2m3.37%no data
1.44%
Woodline Partners LP
888,067US$4.3m196%0.04%
1.42%
State Street Global Advisors, Inc.
880,639US$4.3m18%no data
1.14%
Millennium Management LLC
703,606US$3.4m-22.8%no data
0.91%
Knott Partners Management, LLC
564,549US$2.7m0%0.92%
0.71%
Kennedy Capital Management LLC
437,657US$2.1m52.2%0.04%
0.68%
Northern Trust Global Investments
419,879US$2.0m-1.14%no data
0.65%
Laurion Capital Management LP
402,197US$2.0m-27.8%0.06%
0.49%
Goldman Sachs Group, Investment Banking and Securities Investments
305,082US$1.5m-7.67%no data
0.44%
Exome Asset Management LLC
273,413US$1.3m0%1.17%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.